CorMedix Inc. — Director's Dealing 2010

Apr 1, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CorMedix Inc. (CRMD)
CIK: 0001410098
Period of Report: 2010-03-30

Reporting Person: Houser Mark T. (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-03-30	Common Stock, $0.001 par value per share	C	29304	—	Acquired	42832	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-03-30	12% Convertible Notes	$	C	14652	Disposed		Units consisting of common stoc (14652)	Direct
2010-03-30	Stock option (right to buy)	$3.1250	A	326492	Acquired	2020-03-30	Common Stock, $0.001 par value per share (326492)	Direct
2010-03-30	Warrants issued as a part of Units	$3.4375	C	14652	Acquired	2015-03-24	Common Stock, $0.001 par value per share (14652)	Direct

Footnotes

F1: The 12% Convertible Notes, and all accrued interest thereon, automatically converted into Units upon the consummation of the Company's initial public offering at a
conversion price of $6.50 per Unit, the initial public offering price. Each Unit consists of two shares of common stock and a warrant to purchase one share of common
stock at an exercise price of $3.4375 per share. Each warrant will become exercisable upon the earlier to occur of the expiration of the underwriters' over allotment
option or its exercise in full (in connection with the Company's initial public offering), and will expire on March 24, 2015, or earlier upon redemption.

F2: Each Unit consists of two shares of common stock and a warrant to purchase one share of common stock at an exercise price of $3.4375 per share. Each warrant will
become exercisable upon the earlier to occur of the expiration of the underwriters' over allotment option or its exercise in full (in connection with the Company's initial
public offering), and will expire on March 24, 2015, or earlier upon redemption.

F3: These options vest as follows: 1/3 on March 30, 2011; an additional 1/3 on March 30, 2012; and the remaining 1/3 on March 30, 2013.